Results 71 to 80 of about 2,179 (173)

Drugs for BNCT: BSH and BPA

, 2012
This chapter is based on a shortened version of the investigators brochures from the EORTC clinical trials 11001 and 11011 concerning the boron compounds sodium borocaptate (BSH) and boronophenylalanine (BPA). It summarizes essential information that might be asked by regulatory authorities. The intention of this chapter is to support and to facilitate
Sauerwein, Wolfgang, Bet, Pierre M., Wittig, Andrea   +2 more
openaire   +2 more sources

Development of a New Image Reconstruction Method Using Bayesian Estimation with Limited View-Angle Projection Data for BNCT-SPECT

Applied Sciences
Boron Neutron Capture Therapy (BNCT) is an emerging radiation treatment for cancer, and its challenges are being explored. Systems capable of capturing real-time observations of this treatment’s effectiveness, particularly BNCT-SPECT methods that measure
Fan Lu, Haruka Inamoto, Shuto Takeishi, Shingo Tamaki, Sachie Kusaka, Isao Murata   +5 more
doaj   +1 more source

INEL BNCT Program [PDF]

, 1991
This Bulletin presents a summary of accomplishments and highlights in the Idaho National Engineering Laboratory (INEL) Boron Neutron Capture Therapy (BNCT) Program for April 1991. This bulletin includes information on the brain tumor and melanoma research programs, Power Burst Facility (PBF) technical support and modifications, PBF operations, a ...
openaire   +2 more sources

Comparison of lifetime attributable risk of post-irradiation secondary cancer of boron neutron capture therapy, proton beam therapy, and X-ray therapy for pediatric and adolescent and young adult patients

Clinical and Translational Radiation Oncology
Background and purpose: This study aimed to compare the post-irradiation secondary cancer rates of boron neutron capture therapy (BNCT), proton beam therapy (PBT), and X-ray therapy (XT) in pediatric and Adolescent and Young Adult (AYA) patients with ...
Shunsuke Suzuki, Shintaro Shiba, Hiroki Tanaka, Masashi Yamanaka, Kazuki Matsumoto, Koichi Tokuuye, Motoko Omura   +6 more
doaj   +1 more source

Targeting SLC7A5 in lung squamous cell carcinoma: implications for cancer metabolism shift and boron neutron capture therapy resistance

Oncogenesis
Squamous cell carcinoma (SCC) poses a significant global health challenge due to the lack of effective treatments. Boron neutron capture therapy (BNCT), a targeted particle therapy, has shown promising results in various cancers. SLC7A5, a transporter of
Yen-Ju Lin, Yu-Cheng Wu, Yu-Jui Liu, Wei-Chen Yeh, Yi-Chen Huang, Shen-Ao Zhang, Alvin Chen, Ming-Yi Zheng, Hong-Ming Liu, Fong-In Chou, Shien-Tung Pan, Min-Yuan Chou, Yu-Ting Chou   +12 more
doaj   +1 more source

Antibody-Based Receptor Targeting Using an Fc-Binding Peptide-Dodecaborate Conjugate and Macropinocytosis Induction for Boron Neutron Capture Therapy

ACS Omega, 2020
Ikuhiko Nakase, Ayako Aoki, Yuriko Sakai, Shiori Hirase, Miki Ishimura, Tomoka Takatani-Nakase, Yoshihide Hattori, Mitsunori Kirihata   +7 more
doaj   +1 more source

Microdosimetria in BNCT

La terapia per la cattura neutronica del boro (BNCT) è una forma avanzata di radioterapia sperimentale, per trattare tumori aggressivi e infiltranti quali il glioblastoma. La tecnica consiste nella somministrazione di un farmaco che veicola selettivamente all’interno delle cellule neoplastiche un isotopo del boro non radioattivo, il Boro-10, e il ...
openaire   +1 more source

Potential targets for boron transport in boron neutron capture therapy. [PDF]

Front Oncol
Wei Y, Zhu W, Chen Q, Alnufaei H, Li Y, Ricketts K.   +5 more
europepmc   +1 more source

Integrating measurement and simulation for evaluation of patient-specific whole-body dosimetry in clinical BNCT. [PDF]

Med Phys
Kakino R, Hu N, Sasaki A, Nojiri M, Yoshino Y, Takeno S, Aihara T, Matsubayashi N, Takata T, Tanaka H, Nihei K, Ono K.   +11 more
europepmc   +1 more source

The boron uptake via LAT1 and survival analysis after boron neutron capture therapy in canine hemangiosarcoma cell lines. [PDF]

Front Vet Sci
Iwasaki R, Uchida S, Yoshikawa R, Yoshihashi S, Suzuki M, Mori T.   +5 more
europepmc   +1 more source